Genenta Science S.p.A.
GNTA
Rank in Stocks
#27458
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
Share Price
$0.6851
Last synced: 2026-11-10
Market Cap
$14.54M
Change (1 day)
0.74%
Change (1 year)
-65.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Genenta Science S.p.A. (GNTA)
Category
Healthcare
EPS for Genenta Science S.p.A. (GNTA)
EPS as of December 2025 TTM: $-0.39
According to Genenta Science S.p.A.'s latest financial reports, its current EPS (TTM) is $-0.39. At the end of 2025 the company had an EPS of $-0.39, an increase over its 2024 EPS of $-0.51.
EPS history for Genenta Science S.p.A. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.39 | -0.72% |
| 2025 | $-0.39 | -24.06% |
| 2024 | $-0.51 | -27.93% |
| 2023 | $-0.71 | 40.32% |
| 2022 | $-0.50 | 43.04% |
| 2021 | $-0.35 | -6.62% |
| 2020 | $-0.38 | 34.58% |
| 2019 | $-0.28 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 129.86% |
US
|
|
| $15.66 | -4,144.42% |
US
|
|
| $-7.07 | 1,725.93% |
US
|
|
| $-5.29 | 1,266.22% |
AU
|
|
| $12.73 | -3,388.27% |
BE
|
Questions about Genenta Science S.p.A.'s earnings per share (EPS)
What is Genenta Science S.p.A.'s earnings per share (EPS)?
Genenta Science S.p.A.'s earnings per share (EPS) over the last twelve months is $-0.39, as of Dec 2025.
What was Genenta Science S.p.A.'s earnings per share (EPS) in 2025?
In 2025, Genenta Science S.p.A.'s earnings per share (EPS) was $-0.39, compared with $-0.51 in 2024.
How has Genenta Science S.p.A.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Genenta Science S.p.A.'s earnings per share (EPS) was highest in 2021 ($-0.35) and lowest in 2023 ($-0.71).
How does Genenta Science S.p.A.'s earnings per share (EPS) compare with similar companies?
Genenta Science S.p.A.'s earnings per share (EPS) ($-0.39) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.